首頁 > 市場調查報告書 > 醫療設備

生技設備

病毒過濾市場規模、佔有率及成長分析（按產品、應用、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902378

病毒過濾市場規模、佔有率及成長分析（按產品、應用、最終用戶及地區分類）－2026-2033年產業預測

Virus Filtration Market Size, Share, and Growth Analysis, By Product (Kits and Reagents, Filtration Systems), By Application (Biologicals, Medical Devices), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球病毒過濾市場規模預計在 2024 年達到 58.5 億美元，從 2025 年的 64.5 億美元成長到 2033 年的 141.3 億美元，在預測期（2026-2033 年）內複合年成長率為 10.3%。

全球病毒過濾市場正經歷顯著成長，這主要得益於生物製藥需求的不斷成長，而生物製劑需要嚴格的病毒安全通訊協定。生物製藥公司越來越依賴病毒過濾技術來確保單株抗體和重組蛋白等產品的純度。對病毒去除的重視源於研發投入的增加以及政府旨在加強生物製造能力的扶持措施。關鍵促進因素是對技術創新的高度重視。業界領導企業正在投資先進的薄膜技術，例如奈米纖維和一次性過濾系統，以提高處理量並最大限度地減少污染。該市場的應用範圍也已從傳統的生物製藥擴展到醫療設備、水處理和空氣淨化等領域。此外，自動化和策略夥伴關係正在促進客製化解決方案的快速應用和聯合開發。

全球病毒過濾市場促進因素

全球病毒過濾市場正經歷顯著成長，這主要得益於人們對生物製藥療法和mRNA疫苗的日益關注，而有效的病毒安全措施對於這些療法至關重要。隨著生物製藥和生物製造公司致力於開發包括單株抗體、重組蛋白和基因療法在內的創新治療方法，在生產的每個階段，可靠病毒過濾的需求都至關重要。對病毒安全性的日益重視，加上不斷擴展的生物製藥產品線，促使製造商投資先進的病毒去除過濾器，以滿足嚴格的純度標準。因此，隨著全球生物生產的擴張，病毒過濾系統市場也蓬勃發展。

限制全球病毒過濾市場的因素

全球病毒過濾市場面臨許多限制因素，例如一次性系統和奈米纖維膜等新興病毒過濾技術初期投入成本高。中小型生物製藥公司往往難以撥出足夠的預算來購買昂貴的設備和客製化耗材，以及聘請操作這些系統所需的專業人員。此外，定期更換濾芯和驗證流程等持續性支出也加重了企業的財務負擔。這些成本疊加起來，可能會阻礙企業（尤其是在發展中市場）投資和採用新技術，從而限制其獲得先進的過濾過濾解決方案。

全球病毒過濾市場趨勢

全球病毒過濾市場正經歷著向一次性使用和連續生物程序平台的顯著轉變。製造商擴大採用一次性系統，這不僅降低了交叉污染的風險，還消除了與清潔和驗證相關的停機時間，從而帶來顯著優勢，尤其是在多產品生產設施中。此外，連續生物製程透過不間斷地去除病毒來提高生產效率，在保持嚴格的病毒安全措施的同時最佳化了生產通量。這種模組化、一次性設備的趨勢符合產業對柔軟性的需求，能夠快速部署和重新配置以適應產能變化，最終縮短生物製藥產品的上市時間。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Merck KGaA
Danaher
Sartorius AG
Thermo Fisher Scientific Inc.
GE HealthCare
Charles River Laboratories
Asahi Kasei Medical Co., Ltd.
Sartorius AG
Lonza
Sigma-Aldrich Corporation
Clean Biologics

結論與建議

簡介目錄

Product Code: SQMIG35A3058

Global Virus Filtration Market size was valued at USD 5.85 Billion in 2024 and is poised to grow from USD 6.45 Billion in 2025 to USD 14.13 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The global virus filtration market is experiencing significant growth, fueled by the rising demand for biologics that require stringent viral safety protocols. Biopharmaceutical companies increasingly rely on virus filtration to guarantee the purity of products like monoclonal antibodies and recombinant proteins. The focus on viral clearance is bolstered by heightened R&D investments and supportive government initiatives aimed at enhancing biomanufacturing capabilities. Key drivers include a strong emphasis on technological innovation, with industry leaders investing in advanced membrane technologies, such as nanofiber and single-use filter systems, to improve throughput and minimize contamination. The market is also expanding beyond traditional biologics to include applications in medical devices, water treatment, and air purification, while automation and strategic partnerships are facilitating faster adoption and co-development of tailored solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virus Filtration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virus Filtration Market Segments Analysis

Global Virus Filtration Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Kits and Reagents, Filtration Systems, Services and Other Products. Based on Application, the market is segmented into Biologicals, Medical Devices, Water Purification and Air Purification. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Medical Device Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Virus Filtration Market

The global virus filtration market is experiencing significant growth, driven by the increasing focus on biologic therapies and mRNA-based vaccines that necessitate effective viral safety measures. As biopharmaceutical and biomanufacturing companies strive to develop innovative therapies, including monoclonal antibodies, recombinant proteins, and gene therapies, the demand for reliable virus filtration becomes crucial at every stage of production. This heightened emphasis on viral safety, alongside the expansion of biologics pipelines, compels manufacturers to invest in advanced virus-removal filters to meet rigorous purity standards. Consequently, the market for virus filtration systems is thriving as biological production continues to grow worldwide.

Restraints in the Global Virus Filtration Market

The Global Virus Filtration market faces significant restraints due to the high initial capital costs associated with emerging virus filtration technologies, such as single-use systems and nanofiber membranes. Smaller and mid-sized biopharma companies often struggle to allocate sufficient budgets for costly capital equipment and custom consumables, as well as for the trained personnel required to operate these systems. Furthermore, the ongoing expenses related to routine filter replacements and the validation process add to the financial burden. These combined costs may lead companies, especially in developing markets, to hesitate in investing in and adopting newer technologies, limiting their access to advanced sterilization filtration solutions.

Market Trends of the Global Virus Filtration Market

The Global Virus Filtration market is witnessing a significant shift towards single-use and continuous bioprocessing platforms. Manufacturers are increasingly adopting single-use systems, which not only mitigate the risk of cross-contamination but also reduce downtime associated with cleaning and validation, making them especially advantageous for multiproduct facilities. Additionally, continuous bioprocessing enhances productivity by ensuring uninterrupted viral clearance, which optimizes throughput while maintaining robust viral safety measures. This trend towards modular, disposable units aligns with industry demands for flexibility, allowing for rapid deployment and reconfiguration to adapt to varying production capabilities, ultimately accelerating time-to-market for biopharmaceuticals.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Virus Filtration Market Size by Product & CAGR (2026-2033)

Market Overview
Kits and Reagents
Filtration Systems
Services
Other Products

Global Virus Filtration Market Size by Application & CAGR (2026-2033)

Market Overview
Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Stem Cell Products
Medical Devices
Water Purification
Air Purification

Global Virus Filtration Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Medical Device Companies

Global Virus Filtration Market Size & CAGR (2026-2033)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Medical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clean Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments